AcneFree's Unit Acquisition

AcneFree raised a round of funding on May 03, 2012. Investors include Valeant Pharmaceuticals International.

AcneFree markets and distributes a full range of OTC cleansers and acne treatments. Ambi, CeraVe, and AcneFree were all purchased together for $1.3B from Valeant in January 2017. The $1.3B valuation…

Articles about AcneFree's Unit Acquisition: